---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-033142"
form_type: "8-K"
ticker: "GERN"
cik: "0000886744"
company_name: "GERON CORP"
filed_at: "2024-03-19T23:59:59+00:00"
generated_at: "2026-06-04T14:22:03.516391+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Geron updates risk factors and corporate presentation; no material new event

## Summary
- Updated risk factor disclosure emphasizes sole reliance on imetelstat and risks of clinical trial failures.
- Corporate presentation dated March 2024 made available on company website.
- No specific new clinical, financial, or regulatory event; risks remain consistent with prior filings.

## SEC filing metadata
- accession: 0000950170-24-033142
- form_type: 8-K
- ticker: GERN
- cik: 0000886744
- company_name: GERON CORP
- filed_at: 2024-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/886744/000095017024033142/0000950170-24-033142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/886744/000095017024033142/gern-20240318.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-033142
- JSON: https://secwatch.observer/filing/0000950170-24-033142.json
- Plain text: https://secwatch.observer/filing/0000950170-24-033142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.